Trial
NCT02372305
Comparison of FlexHD and Alloderm Outcomes in Breast Reconstructive Surgery
Phase IVWITHDRAWNEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
University of Arkansas
Collaborators
—
Condition
Breast Neoplasm
Intervention
FlexHD
Why stopped
PI is no longer at institution. IRB closed study due to lack of response from PI
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-07-18